Marshall Jay Glesby MD PhD
HIV/AIDS Medicine
Professor of Medicine, Weill Cornell Medical College
Join to View Full Profile
525 E 68th St# BakerNew York, NY 10065
Phone+1 212-746-7134
Fax+1 212-746-8852
Dr. Glesby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1992 - 1996- Johns Hopkins UniversityResidency, Internal Medicine, 1989 - 1992
- Johns Hopkins University School of MedicineClass of 1989
Certifications & Licensure
NY State Medical License 1997 - 2027
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2013-2014
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
Clinical Trials
- Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection
- Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
- Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance Start of enrollment: 2005 Mar 01
Publications & Presentations
PubMed
- Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis.Triin Umbleja, Mohammad U Zafar, Sara McCallum, Arijeet K Gattu, Markella V Zanni
The Lancet. HIV. 2026-05-01 - Clinical Outcomes of Mpox Disease in Patients Treated With Tecovirimat.Ciarra Leocadio, Elizabeth A Garcia, Maura Lash, Jonathan Berardi, Justin Chan
Clinical Infectious Diseases. 2026-04-30 - 3 citationsTecovirimat for the Treatment of Mpox.Jason Zucker, William A Fischer 2nd, Lu Zheng, Caitlyn McCarthy, Pooja T Saha
The New England Journal of Medicine. 2026-02-26
Journal Articles
- Moderate Alcohol Use Is Not Associated with Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Women: A Prospective Cohort StudyPhyllis C Tien, Marshall J Glesby, Michael Augenbraun, Clinical Infectious Diseases
Lectures
- CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other
- Treatment of HIV-associated lipodystrophyGlesby MJ
http://www.uptodate.com/contents/treatment-of-hiv-associated-lipodystrophy
UpToDate, Wolters Kluwer Health - 2012-10-05
Press Mentions
HIV Patients Fare Well with Mpox TreatmentMay 5th, 2023- NIH Grant Funds Antibiotic Trial for Patients with HIV and EmphysemaDecember 13th, 2022
- How a Select Few People Have Been Cured of HIVOctober 5th, 2022
Grant Support
- 1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH TrialWEILL MEDICAL COLL OF CORNELL UNIV2021–2026
- Complications Of Chronic Viral InfectionsNational Institute Of Allergy And Infectious Diseases2008–2011
- A5229 Lipoatrophy StudyNational Center For Research Resources2007
- Study Of Safety And Efficacy Of Rhgh A/O Rosiglitazone In HIVNational Center For Research Resources2006–2007
- Growth Hormone And Rosiglitazone For Visceral AdoposityNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
